Literature DB >> 10724645

Matrix metalloproteinase inhibitor: differential effects on pulmonary neutrophil and monocyte sequestration following cardiopulmonary bypass.

U G McCann1, L A Gatto, B Searles, D E Carney, C J Lutz, A L Picone, H J Schiller, G F Nieman.   

Abstract

UNLABELLED: Acute respiratory distress syndrome (ARDS) following cardiopulmonary bypass (CPB), also known as "post-pump" or "post-perfusion syndrome" (PPS), results from sequential priming and activation of neutrophils. We hypothesized that chemically modified tetracycline (CMT-3) an inhibitor of neutrophil matrix metalloproteinase (MMP) and elastase, would prevent PPS. We performed histometric analysis of lung tissue from our porcine PPS model to correlate cellular sequestration and histologic injury with CMT-3 treatment.
METHODS: Yorkshire pigs were randomized into five groups: Control (n = 3); CPB (n = 5); femoral-femoral bypass 1 hour; LPS (n = 7), Escherichia coli lipopolysaccharide (1 microgram/kg); CPB + LPS (n = 6); and CPB + LPS + CMT (n = 5), sequential insults and CMT-3. Protocol histometric analysis defined cellular and tissue components of lung injury.
RESULTS: CMT-3 decreased neutrophil sequestration in the CPB + LPS + CMT-3 group (p < 0.0001 vs. CPB + LPS). There were no differences in monocytes between CPB + LPS and CPB + LPS + CMT treatment groups.
CONCLUSIONS: CMT-3 attenuates neutrophil sequestration but has no effect on mononuclear sequestration in our PPS model. This finding supports current research on leukocyte chemokines and has important implications regarding mechanisms of CMT-3. Despite lack of monocyte response to CMT-3, PPS was prevented by inhibiting neutrophils alone; confirming the primary role of neutrophils in PPS.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10724645

Source DB:  PubMed          Journal:  J Extra Corpor Technol        ISSN: 0022-1058


  5 in total

1.  Inhibition of matrix metalloproteinase-9 with low-dose doxycycline reduces acute lung injury induced by cardiopulmonary bypass.

Authors:  Chengxin Zhang; Wenhui Gong; Haiyuan Liu; Zhixiang Guo; Shenglin Ge
Journal:  Int J Clin Exp Med       Date:  2014-12-15

Review 2.  Transepithelial migration of neutrophils: mechanisms and implications for acute lung injury.

Authors:  Rachel L Zemans; Sean P Colgan; Gregory P Downey
Journal:  Am J Respir Cell Mol Biol       Date:  2008-10-31       Impact factor: 6.914

3.  Metalloproteinase inhibitors, nonantimicrobial chemically modified tetracyclines, and ilomastat block Bacillus anthracis lethal factor activity in viable cells.

Authors:  Salih S Kocer; Stephen G Walker; Brad Zerler; Lorne M Golub; Sanford R Simon
Journal:  Infect Immun       Date:  2005-11       Impact factor: 3.441

4.  Repurposing tetracyclines for acute respiratory distress syndrome (ARDS) and severe COVID-19: a critical discussion of recent publications.

Authors:  Jose Garrido-Mesa; Kate Adams; Julio Galvez; Natividad Garrido-Mesa
Journal:  Expert Opin Investig Drugs       Date:  2022-03-23       Impact factor: 6.498

Review 5.  Immunomodulation by Tetracyclines in the Critically Ill: An Emerging Treatment Option?

Authors:  Andrea Sauer; Christian Putensen; Christian Bode
Journal:  Crit Care       Date:  2022-03-22       Impact factor: 9.097

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.